Ayer Capital Management
Latest statistics and disclosures from Ayer Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Grifols S A, Celgene Corp right 12/31/2011, ARTC, ELGX, HOLX. These five stock positions account for 47.73% of Ayer Capital Management's total stock portfolio.
- Added to shares of Grifols S A (+$14.11M), CVS (+$5.22M), ARAY, GILD, CYCC, Peregrine Pharmaceuticals Inc. cmn, Orthofix International Nv Com Stk.
- Started new stock positions in GILD, Orthofix International Nv Com Stk, Grifols S A, CVS, CYCC, ARAY.
- Reduced shares in these stocks: Grifols S A Sponsored Adr R (-$21.14M), TEVA (-$12.92M), BSX (-$9.16M), Insmed (-$9.03M), ELGX (-$6.41M), PPHM (-$6.35M), MCK (-$5.81M), NVAX (-$5.24M), ARIA, ARTC.
- Sold out of its positions in ATRC, Cyclacel Pharmaceuticals, Grifols S A Sponsored Adr R, HMA, NVAX, OMER, Biomira Inc Cmn Stock cmn, PTN.
- As of March 31, 2013, Ayer Capital Management has $118.00M in assets under management (AUM). Assets under management dropped from a total value of $190.92M to $118.00M.
- Independent of market fluctuations, Ayer Capital Management was a net seller by $87.68M worth of stocks in the most recent quarter.
Ayer Capital Management portfolio companies for quarter ending March 2013
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| Grifols S A | 11.96 | NEW | 486431 | 29.01 | 0.00 | |
| Celgene Corp right 12/31/2011 | 11.24 | -15.00% | 1875422 | 7.07 | 0.00 | |
| ARTC | ArthroCare Corporation | 9.82 | -26.00% | 333250 | 34.76 | 33.10 |
| ELGX | Endologix | 8.32 | -39.00% | 607930 | 16.15 | 14.02 |
| HOLX | Hologic | 6.39 | -28.00% | 333879 | 22.60 | 20.24 |
| BSX | Boston Scientific Corporation | 5.65 | -57.00% | 853147 | 7.81 | 9.06 |
| CAH | Cardinal Health | 5.26 | -7.00% | 148989 | 41.62 | 47.21 |
| TEVA | Teva Pharmaceutical Industries | 5.07 | -68.00% | 150690 | 39.68 | 39.99 |
| UHS | Universal Health Services | 4.57 | -20.00% | 84392 | 63.87 | 67.04 |
| ARIA | Ariad Pharmaceuticals | 4.48 | -48.00% | 292106 | 18.09 | 18.34 |
| CVS | CVS Caremark Corporation | 4.42 | NEW | 94844 | 54.99 | 57.98 |
| MCK | McKesson Corporation | 4.32 | -53.00% | 47259 | 107.96 | 117.24 |
| Express Scripts Holding | 3.89 | -45.00% | 79629 | 57.65 | 0.00 | |
| Peregrine Pharmaceuticals Inc. cmn | 2.84 | +25.00% | 2500000 | 1.34 | 0.00 | |
| ARAY | Accuray Incorporated | 2.29 | NEW | 583044 | 4.64 | 5.25 |
| SHP | ShangPharma | 1.93 | -51.00% | 254477 | 8.95 | 0.00 |
| Insmed | 1.76 | -81.00% | 277781 | 7.49 | 0.00 | |
| Chemocentryx | 1.51 | -67.00% | 128838 | 13.82 | 0.00 | |
| GILD | Gilead Sciences | 1.29 | NEW | 31226 | 48.93 | 55.65 |
| CYCC | Cyclacel Pharmaceuticals | 1.05 | NEW | 220593 | 5.59 | 3.00 |
| PPHM | Peregrine Pharmaceuticals | 0.79 | -87.00% | 699935 | 1.34 | 1.70 |
| THLD | Threshold Pharmaceuticals | 0.57 | -81.00% | 146321 | 4.61 | 5.48 |
| Biolinerx Ltd-spons | 0.40 | -75.00% | 277604 | 1.68 | 0.00 | |
| Orthofix International Nv Com Stk | 0.19 | NEW | 6100 | 35.90 | 0.00 |
Past 13F-HR SEC Filings for Ayer Capital Management
- Ayer Capital Management 2012 Q4 - filed Feb. 14, 2013
- Ayer Capital Management 2012 Q3 - filed Nov. 15, 2012
- Ayer Capital Management 2012 Q2 - filed Aug. 16, 2012
- Ayer Capital Management 2012 Q1 - filed May 15, 2012
- Ayer Capital Management 2011 Q3 - filed Nov. 14, 2011
- Ayer Capital Management 2011 Q2 - filed Aug. 15, 2011
- Ayer Capital Management 2011 Q1 - filed May 17, 2011
- Ayer Capital Management 2010 Q4 - filed Feb. 15, 2011